Association between late-onset Alzheimer's disease and microsatellite polymorphisms in intron II of the human toll-like receptor 2 gene

Neuroscience Letters

Volumn 489, Issue 3, 2011, Pages 164-167

  Wang, Li Zhu ^a   Tian, Yan ^a   Yu, Jin Tai ^a   Chen, Wei ^a   Wu, Zhong Chen ^a   Zhang, Qun ^a   Zhang, Wei ^a   Tan, Lan ^a  

^a QINGDAO UNIVERSITY   (China)

Author keywords

Alzheimer's disease; Microsatellite polymorphism; Toll like receptor 2

Indexed keywords

APOLIPOPROTEIN E4; GUANINE; THYMINE; TOLL LIKE RECEPTOR 2;

ALZHEIMER DISEASE; ARTICLE; CHINESE; DISEASE COURSE; DNA POLYMORPHISM; GENE FREQUENCY; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HUMAN; INTRON; MICROSATELLITE MARKER; PATHOGENESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

AGED; ALLELES; ALZHEIMER DISEASE; ASIAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INTRONS; MALE; MICROSATELLITE REPEATS; POLYMORPHISM, GENETIC; TOLL-LIKE RECEPTOR 2;

EID: 78751575410     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2010.12.008     Document Type: Article

References (42)

1. Akira S., Uematsu S., Takeuchi O. Pathogen recognition and innate immunity. Cell 2006, 124:783-801.
2. Akiyama H., Barger S., Barnum S., Bradt B., Bauer J., Cole G.M., Cooper N.R., Eikelenboom P., Emmerling M., Fiebich B.L., Finch C.E., Frautschy S., Griffin W.S., Hampel H., Hull M., Landreth G., Lue L., Mrak R., Mackenzie I.R., McGeer P.L., O'Banion M.K., Pachter J., Pasinetti G., Plata-Salaman C., Rogers J., Rydel R., Shen Y., Streit W., Strohmeyer R., Tooyoma I., Van Muiswinkel F.L., Veerhuis R., Walker D., Webster S., Wegrzyniak B., Wenk G., Wyss-Coray T. Inflammation and Alzheimer's disease. Neurobiol. Aging 2000, 21:383-421.
3. Bertram L., Tanzi R.E. Thirty years of Alzheimer's disease genetics: the implications of systematic meta-analyses. Nat. Rev. Neurosci. 2008, 9:768-778.
4. Boraska Jelavić T., Barisić M., Drmic Hofman I., Boraska V., Vrdoljak E., Peruzović M., Hozo I., Puljiz Z., Terzić J. Microsatelite GT polymorphism in the Toll-like receptor 2 is associated with colorectal cancer. Clin. Genet. 2006, 70:156-160.
5. Chen K., Iribarren P., Hu J., Chen J., Gong W., Cho E.H., Lockett S., Dunlop N.M., Wang J.M. Activation of Toll-like receptor 2 on microglia promotes cell uptake of Alzheimer disease-associated amyloid beta peptide. J. Biol. Chem. 2006, 281:3651-3659.
6. Combarros O., Infante J., Rodriguez E., Llorca J., Pena N., Fernandez-Viadero C., Berciano J. CD14 receptor polymorphism and Alzheimer's disease risk. Neurosci. Lett. 2005, 380:193-196.
7. Donohoe G.G., Salomäki A., Lehtimäki T., Pulkki K., Kairisto1 V. Rapid identification of ApolipoproteinE genotypes by multiplex amplification refractory mutation system PCR and capillary gelelectrophoresis. Clin. Chem. 1999, 45:143-146.
8. Eikelenboom P., Veerhuis R., Scheper W., Rozemuller A.J., van Gool W.A., Hoozemans J.J. The significance of neuroinflammation in understanding Alzheimer's disease. J. Neural. Transm. 2006, 113:1685-1695.
9. Fassbender K., Walter S., Kuhl S., Landmann R., Ishii K., Bertsch T., Stalder A.K., Muehlhauser F., Liu Y., Ulmer A.J., Rivest S., Lentschat A., Gulbins E., Jucker M., Staufenbiel M., Brechtel K., Walter J., Multhaup G., Penke B., Adachi Y., Hartmann T., Beyreuther K. The LPS receptor (CD14) links innate immunity with Alzheimer's disease. FASEB J. 2004, 18:203-205.
10. Gordon S. Pattern recognition receptors: doubling up for the innate immune response. Cell 2002, 111:927-930.
11. Hardy J., Selkoe D.J. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 2002, 297:353-356.
12. Hedley R., Hallmayer J., Groth D.M., Brooks W.S., Gangy S.E., Martins R.N. Association of interleukin-1 polymorphisms with Alzheimer's disease in Australia. Ann. Neurol. 2002, 51:795-797.
13. Jana M., Palencia C.A., Pahan K. Fibrillar amyloid-beta peptides activate microglia via TLR2: implications for Alzheimer's disease. J. Immunol. 2008, 181:7254-7262.
14. Kim H.J., Lee H.W., Lee J.E., Joh J.S., Han S.K., Shim Y.S., Yim J.J. Lack of association between the microsatellite polymorphism in intron 2 of human Toll-like receptor 2 gene and bronchiectasis among Koreans. Respirology 2007, 12:49-53.
15. Letiembre M., Liu Y., Walter S., Hao W., Pfander T., Wrede A., Schulz-Schaeffer W., Fassbender K. Sceening of innate immune receptors in neurodegenerative disease: a similar pattern. Neurobiol. Aging 2009, 30:759-768.
16. Liu Y., Walter S., Stagi M., Cherny D., Letiembre M., Schulz-Schaeffer W., Heine H., Penke B., Neumann H., Fassbender K. LPS receptor (CD14): a receptor for phagocytosis of Alzheimer's amyloid peptide. Brain 2005, 128:1778-1789.
17. Lee E.Y., Yim J.J., Lee H.S., Lee Y.J., Lee E.B., Song Y.W. Dinucleotide repeat polymorphism in intron II of human Toll-like receptor 2 gene and susceptibility to rheumatoid arthritis. Int. J. Immunogenet. 2006, 33:211-215.
18. Ma S.L., Tang N.L., Lam L.C., Chiu H.F. Lack of association of the interleukin-1 beta gene polymorphism with Alzheimer's disease in a Chinese population. Dement. Geriatr. Cogn. Disord. 2003, 16:265-268.
19. McKhann G., Drachman D., Folstein M., Katzman R., Price D., Stadlan E.M. Clinical diagnosis of Alzheimer's disease: report of the NINCDSADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984, 34:939-944.
20. Minoretti P., Gazzaruso C., Vito D.C., Emanuele E., Bianchi M., Coen E.R., Eino M., Geroldi D. Effect of the functional toll-like receptor Asp299 Gly polymorphismon susceptibility of late-onset Alzheimer's disease. Neurosci. Lett. 2006, 391:147-149.
21. Moore C.E., Segal S., Berendt A.R., Hill A.V., Day N.P. Lack of association between Toll-like receptor2 polymorphisms and susceptibility to severe disease caused by Staphylococcus aureus. Clin. Diagn. Lab. Immunol. 2004, 11:1194-1197.
22. Reed-Geaghan E.G., Savage J.C., Hise A.G., Landreth G.E. CD14 and Toll-like receptors 2 and 4 are required for fibrillar Aβ-stimulated microglial activation. J. Neurosci. 2009, 29:11982-11992.
23. Richard K.L., Filali M., Pre'fontaine P., Rivest S. Toll-like receptor 2 acts as a natural innate immune receptor to clear amyloid β1-42 and delay the cognitive decline in a mouse model of Alzheimer's disease. J. Neurosci. 2008, 28:5784-5793.
24. Roberts J., Scott A.C., Howard M.R., Breen G., Bubb V.J., Klenova E., Quinn J.P. Differential regulation of the serotonin transporter gene by lithium is mediated by transcription factors, CCCTC binding protein and Y-box binding protein 1, through the polymorphic intron 2 variable number tandem repeat. J. Neurosci. 2007, 27:2793-2801.
25. Selkoe D.J. Toward a comprehensive theory for Alzheimer's disease Hypothesis: Alzheimer's diseaseis caused by the cerebral accumulation and cytotoxicity of amyloid beta-protein. Ann. N. Y. Acad. Sci. 2000, 924:17-25.
26. Tahara K., Kim H.D., Jin J.J., Maxwell J.A., Li L., Fukuchi K.I. Roll of toll-like receptor signaling in Aβ uptake and clearance. Brain 2006, 129:3006-3019.
27. Takagi Y., Masamune A., Kume K., Satoh A., Kikuta K., Watanabe T., Satoh K., Hirota M., Shimosegawa T. Microsatellite polymorphism in intron 2 of human toll-like receptor 2 gene is associated with susceptibility to acute pancreatitis in Japan. Hum. Immunol. 2009, 70:200-204.
28. Tan L., Schedl P., Song H.J., Garza D., Konsolaki M. The Toll NF kappaB signaling pathway mediates the neuropathological effects of the human Alzheimer's Abeta42 polypeptide in Drosophila. PLoS One 2008, 3:e3966.
29. Tanzi R.E., Bertram L. Twenty years of the Alzheimer's disease amyloid hypothesis: a genetic perspective. J. Cell. 2005, 120:545-555.
30. Tsuge M., Hamamoto R., Silva F.P., Ohnishi Y., Chayama K., Kamatani N., Furukawa Y., Nakamura Y. A variable number of tandem repeats polymorphism in an E2F-1 binding element in the 5' flanking region of SMYD3 is a risk factor for human cancers. Nat. Genet. 2005, 37:1104-1107.
31. Udan M.L., Ajit D., Crouse N.R., Nichols M.R. Toll-like receptors 2 and 4 mediate A beta(1-42) activation of the innate immune response in a human monocytic cellline. J. Neurochem. 2008, 104:524-533.
32. Verdier Y., Zarandi M., Penke B. Amyloid beta-peptide interactionswith neuronal and glial cell plasma membrane: binding sites and implications for Alzheimer's disease. J. Pept. Sci. 2004, 10:229-248.
33. Veltkamp M., Wijnen P.A., van Moorsel C.H., Rijkers G.T., Ruven H.J., Heron M., Bekers O., Claessen A.M., Drent M., van den Bosch J.M., Grutters J.C. Linkage between Toll-like receptor (TLR)2 promotor and intron polymorphisms: functional effects and relevance to sarcoidosis. Clin. Exp. Immunol. 2007, 149:453-462.
34. Walter S., Letiembre M., Liu Y., Heine H., Penke B., Hao W., Bode B., Manietta N., Walter J., Schulz-Schuffer W., Fassbender K. Role of the toll-like receptor 4 in neuroinflammation in Alzheimer's disease. Cell. Physiol. Biochem. 2007, 20:947-956.
35. Xue Y., Jin L., Li A.Z., Wang H.J., Li M., Zhang Y.X., Wang Y., Li J.C. Microsatellite polymorphisms in intron 2 of the toll-like receptor 2 gene and their association with susceptibility to tuberculosis in Han Chinese. Clin. Chem. Lab. Med. 2010, 48:785-789.
36. Yim J.J., Ding L., Schaffer A.A., Park G.Y., Shim Y.S., Holland S.M. A microsatellite polymorphism in intron2 of human Toll-like receptor2 gene: functional implications and racial differences. FEMS Immunol. Med. Microbiol. 2004, 40:163-169.
37. Yim J.J., Kim H.J., Kwon O.J., Koh W.J. Association between microsatellite polymorphisms in intron II of the human Toll-like receptor 2 gene and nontuberculous mycobacterial lung disease in a Korean population. Hum. Immunol. 2008, 69:572-576.
38. Yim J.J., Lee H.W., Lee H.S., Kim Y.W., Han S.K., Shim Y.S., Holland S.M. The association between microsatellite polymorphisms in intron II of the human Toll-like receptor 2 gene and tuberculosis among Koreans. Genes Immun. 2006, 7:150-155.
39. Yu J.T., Li L., Zhu Q.X., Zhang Q., Zhang W., Wu Z.C., Guan J., Tan L. Implication of CLU gene polymorphisms in Chinese patients with Alzheimer's disease. Clin. Chim. Acta 2010, 411:1516-1519.
40. Yu J.T., Song J.H., Wang N.D., Wu Z.C., Zhang Q., Zhang N., Zhang W., Xuan S.Y., Tan L. Implication of IL-33 gene polymorphism in Chinese patients with Alzheimer's disease. Neurobiol. Aging 2010, 10.1016/j.neurobiolaging.2010.07.003.
41. Yu J.T., Tan L., Song J.H., Sun Y.P., Chen W., Miao D., Tian Y. Interleukin-18 promoter polymorphisms and risk of late onset Alzheimer's disease. Brain Res. 2009, 1253:169-175.
42. Zhang Q., Yu J.T., Zhu Q.X., Zhang W., Wu Z.C., Miao D., Tan L. Complement receptor 1 polymorphisms and risk of late-onset Alzheimer's disease. Brain Res. 2010, 1348:216-221.